Zitat:
By TSC Staff
11/5/2004 9:29 AM EST
Merck (MRK:NYSE - commentary - research) shares were unchanged early Friday after the latest development in the Vioxx recall saga.
The drugmaker early today said it had posted a scientific critique on its Web site to "further clarify for the scientific community why Merck disagrees with the conclusions" of an article published in this week's issue of The Lancet, the British medical journal.
In a brief statement, Merck reiterated its disagreement with the methodology used. The British medical journal reported there was sufficient evidence of the dangerous side effects of the drug by the end of 2000, but the data was not analyzed properly.
Questions about Merck's handling of safety issues surrounding Vioxx and the related risk of heart attacks prior to its eventual recall in September continue to dog the drugmaker, further devaluing its already-beaten-down stock. Merck has repeatedly said it made the recall at the right time, based on the best information available at the time.
The Vioxx recall has raised new questions about the tenure of Merck Chairman and CEO Raymond Gilmartin, who is not scheduled to retire until 2006. Gilmartin's reign has been marked by a series of stumbles in the last couple years, culminating in the recall of Vioxx, its No. 2 drug.
Merck shares were down 2 cents to $27, having touched an eight-year low earlier this week. The stock closed at $45.07 on Sept. 29, the day before the company said it was pulling Vioxx from the market.
|
Quelle:
Mein Kommentar: Die Informationen von Merck sind wahrscheinlich
hier zu finden. Aber sie interessieren momentan an der Börse keinen. Mich würde sehr interessieren:
1. ob die Fondsmanager nur so naiv sind, oder
2. ob der Wert gezielt leerverkauft wird.
In dem ersten Fall geht es bis zur ersten gewonnenen Verhandlung sicher runter, aber im zweiten könnte ein Turnaround früher kommen, denn dann spielen Nachrichten eine untergeordnete Rolle.
@Alle:
kann man irgendwo die Leerverkäufe für Merck sehen? Wäre sehr dankbar für diese Info!